Azosemide

阿佐赛米

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAzosemide
Drug Alias Nameazosemida阿唑噻米azosemidum阿佐塞米氮唑速尿 +[14
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/potassium-transporting ATPase inhibitors
TargetsSodium/potassium-transporting ATPase
Therapy Area/IndicationsEdema
Global Approved IndicationsEdema
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1981/01/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsEdema
Inactive IndicationsN/A

Other Information

ATC CodeC03